ArticleCureus2024
A Comprehensive Analysis of Clinical Presentations, Laboratory Findings, and Etiologies of Pancytopenia: A Tertiary Care Experience.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epidemiological and clinicopathological profile of pancytopenia: A cross-sectional study.Bioinformation · 2026Article
- Clinical and etiological profile of anemia in a clinical hematology department of North Africa : A cross-sectional study.Leukemia research reports · 2026Article
- Evaluation of Etiological Causes and Incidence of Pancytopenia: A Case Series from a Tertiary Care Center.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Pancytopenia, while a common manifestation of a multitude of diseases, remains a relatively lesser-researched topic, especially in developing countries. Its management depends largely on identifying the etiology, which can range from simple infections to more sinister causes like leukemia. This study aims to investigate the clinical presentations, hematological findings, and etiologies of pancytopenia in a developing country. Methods A cross-sectional study was conducted at Hayatabad Medical Complex, Peshawar, and included 106 patients who were diagnosed with pancytopenia. Thorough demographic details, histories, clinical examinations, laboratory investigations, bone marrow biopsies, and final diagnoses were recorded and analyzed using statistical tools. Results Pancytopenia was most common in the age group 11-30 years with a male-to-female ratio of 1.4:1. Infections were the leading etiology (17.9%), followed by megaloblastic anemia (17%), hypersplenism (16%), and malignancy (15.1%). Among infections, enteric fever was the most frequently observed cause. The most common presentation was with signs and symptoms of anemia, followed by infections and thrombocytopenia. The most common blood smear finding case-wise was a combination of anisocytosis, microcytosis, and target cells. In patients who underwent bone marrow biopsy, the commonest finding (34%) was suggestive of malignancy with hypercellularity and abnormal cells. Aplastic anemia, hypersplenism, and malignancy were associated with a retic count of <1.5%. Platelet counts of less than 50,000 were associated with the presence of signs and symptoms of thrombocytopenia. Conclusion Pancytopenia can be a presenting feature of a reversible condition like underlying infection and megaloblastic anemia, which contribute a major portion of its etiologies. Early diagnosis and treatment can reverse pancytopenia and prevent over-investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.